# Study of Metamucil on Blood Glucose and HbA1c in Type II NIDDM Subjects

> **NCT01582282** · PHASE4 · TERMINATED · sponsor: **Procter and Gamble** · enrollment: 37 (actual)

## Conditions studied

- Non-Insulin-dependent Diabetes Mellitus

## Interventions

- **DIETARY_SUPPLEMENT:** placebo
- **DIETARY_SUPPLEMENT:** 3.4 g psyllium BID
- **DIETARY_SUPPLEMENT:** 6.8g psyllium BID

## Key facts

- **NCT ID:** NCT01582282
- **Lead sponsor:** Procter and Gamble
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 1988-05
- **Primary completion:** 1990-01
- **Final completion:** 1990-01
- **Target enrollment:** 37 (ACTUAL)
- **Why stopped:** due to slow enrollment
- **Last updated:** 2012-11-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01582282

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01582282, "Study of Metamucil on Blood Glucose and HbA1c in Type II NIDDM Subjects". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01582282. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*